Sun, Apr 30, 2017 | updated 01:03 AM IST

Two differing medications safe for patient undergoing heart procedure

Updated: Nov 14, 2016 11:38 IST      
Two differing medications safe for patient undergoing heart procedure

Washington D.C. [USA], Nov.14 (ANI): According to a new study, two differing blood clot prevention medications are safe and effective for patients undergoing a non-surgical procedure to open blood vessels narrowed by plaque buildup.

The scientific community has proposed both medications as potentially superior to longer-term anticoagulation treatments for patients undergoing percutaneous coronary intervention.

The new study sought to discover which of the two short-term treatment methods --using the drug heparin combined with a short-term (less than six hours) infusion of tirofiban, or short-term periprocedural bivalirudin, another medication that helps prevent blood clots during the procedure -- was more effective.

Through this observational study of patients undergoing successful elective percutaneous coronary intervention, the Intermountain researchers found that the risk after 30 days of major bleeding, and one-year risk of death, heart attack and urgent repeat PCI, was low and not significantly different between the two treatment methods.

"Bivalirudin has been considered the gold standard for reducing bleeding during percutaneous coronary intervention, but our study shows heparin plus short-term tirofiban is just as good and possibly better," said cardiologist J. Brent Muhlestein. "The results certainly justify a randomized clinical trial to explore identified trends."

Researchers studied results from patients who underwent percutaneous coronary intervention between January 2013 and December 2015. Of the 857 patients enrolled in the study, 402 received heparin plus short-term tirofiban treatment and 455 received bivalirudin. The patients were between the ages of 51 and 78.

There was a slight reduction in major bleeding and death with the use of heparin plus short-term tirofiban over bivalirudin alone, but due to the overall low incidence of adverse events, the difference did not reach statistical significance.

The 30-day incidence of TIMI major bleeding score was 1.2 percent for patients treated with heparin and tirofiban and 3.1 percent for bivalirudin patients.

The study was presented during the American Heart Association Scientific Sessions in New Orleans.(ANI)

Online support can help people with bipolar disorder

Updated: Apr 29, 2017 14:43 IST     

Washington D.C. [USA], April 29 (ANI): Briton researchers have developed a cheap and accessible online relapse prevention tool for people, who seek support following treatment of Bipolar Disorder.

Full Story >>

Ailing from chronic inflammation? Here is why

Updated: Apr 29, 2017 09:05 IST     

Washington D.C. [USA], Apr 29 (ANI): Are you suffering from chronic intestinal disorders? Blame your body's immune system for that.

Full Story >>

Bullying can lead to desire for 'cosmetic surgery' in teens

Updated: Apr 29, 2017 08:47 IST     

Washington D.C. [USA], Apr 29 (ANI): According to a new study, young adults who are involved in bullying, whether victims or perpetrators, are more likely to express the desire for cosmetic surgery in order to become more attractive.

Full Story >>

New blood test may predict diabetes better

Updated: Apr 28, 2017 16:00 IST     

Washington D.C. [USA], Apr 28 (ANI): A team of researchers has come up with a new blood test that may better predict gestational diabetes.

Full Story >>

Turns out, e-cigarettes can help smokers kick the butt

Updated: Apr 28, 2017 14:11 IST     

Washington D.C. [USA], Apr 28 (ANI): Smokers rejoice! As a recent study suggests that your plan to kick the cigarette addiction by turning to the electronic version of butts won't go up in smoke.

Full Story >>

Affordable lab tests now at your doorstep

Updated: Apr 28, 2017 06:41 IST     

New Delhi [India], April 28 (ANI): Before going for any medical test, now compare the rates of different path-labs with just a click.

Full Story >>

Deal with depression in natural way

Updated: Apr 28, 2017 03:19 IST     

New Delhi [India], April 28 (ANI): Depression is world's leading illness and is one of the major reasons for suicides globally, says the World Health Organization (WHO). The story in India is no different.

Full Story >>

Parkinson's disease starts in gut: Study

Updated: Apr 27, 2017 10:03 IST     

Washington D.C. [USA], Apr 27 (ANI): A recent study suggests that parkinson's disease, a disorder of the central nervous system, may start in the gut and spread to the brain via the vagus nerve.

Full Story >>

Lung for Long: Gasp No More

Updated: Apr 26, 2017 18:45 IST     

New Delhi [India], Apr 26 (ANI-Businesswire India): Lungs in Delhi seem to be in dire straits. In the midst of ever thickening air pollution and lifestyle gone astray, lung power is ebbing fast. Data emerging from April 25 lung health camp organized in iconic Press Club of India (PCI) on the occasion of World Asthma Day pressed panic button as regards lung health of the capital city.

Full Story >>

Risk of obesity influenced by changes in our genes

Updated: Apr 26, 2017 15:22 IST     

New Delhi [India], Apr 26 (ANI): According to new study, a child's risk of obesity while growing up can be influenced by modifications to their DNA prior to birth.

Full Story >>

Patient with rare knee cancer undergoes life saving surgery

Updated: Apr 26, 2017 13:52 IST     

New Delhi [India], Apr 26 (ANI): A resident of Ganganager, in Rajasthan, was diagnosed of Large Soft Tissue Sarcoma (9Kg), with Neuro Vascular involvement.

Full Story >>

Here`s how protein impacts intellectual disability

Updated: Apr 26, 2017 07:36 IST     

Washington D.C. [USA], Apr 26 (ANI): A new study has paved the way for the potential treatments of intellectual disability and other neurodevelopmental disorders.

Full Story >>

Stem cells can help identify neuronal defects, suggests Study

Updated: Apr 25, 2017 12:26 IST     

Washington D.C. [USA], Apr 25 (ANI): According to a recent study, the researchers used stem cells derived from patients with Angelman syndrome to identify the underlying cellular defects that cause the rare neurogenetic disorder.

Full Story >>

#WorldMalariaDay: Effective steps to prevent Malaria

Updated: Apr 25, 2017 11:01 IST     

New Delhi [India], Apr 25 (ANI): The theme for World Malaria Day this year is "End Malaria for Good".

Full Story >>

Artificial Intelligence may help in diagnosing Tuberoculosis

Updated: Apr 25, 2017 11:01 IST     

Washington D.C. [USA], Apr 25 (ANI): If you are a patient of Tuberculosis, then we might have some good news for you.

Full Story >>

London [UK], Apr 25 (ANI): According to a new study, only one in five victims with serious injuries caused by child abuse in England and Wales gets treated at a major trauma centre.

Full Story >>

Gene reveals cause of fatal childhood disorder: Study

Updated: Apr 24, 2017 17:51 IST     

New Delhi [India], Apr 24 (ANI): A gene, involved in brain development, which can lead to severe disability and infant death, has been identified by scientists.

Full Story >>

Alcohol: the modern age liver killer

Updated: Apr 24, 2017 17:51 IST     

New Delhi [India], Apr 24 (ANI): Alcohol is predominantly metabolized through liver, hence its cumulative toxicity over years play important role in liver diseases or pancreatic diseases.

Full Story >>

Washington D.C. [USA], April 24 (ANI): Due to increasing deaths because of prostate cancer among men, US researchers have suggested a special screening more frequently and at an early age to avoid the development of preclinical prostate cancer - that is not symptomatic - to advanced stages.

Full Story >>

Love guzzling diet sodas? Here is why you should NOT

Updated: Apr 24, 2017 07:02 IST     

New York [U.S.], Apr. 24 (ANI): Still downing gallons of diet soda despite knowing that it wrecks your body? Maybe the knowledge of artificially sweetened beverages taking a toll on your brain as well ought to make an impact on your unhealthy habit.

Full Story >>